Literature DB >> 19138763

Prevalence of functional gastrointestinal disorders in patients with fibromyalgia and the role of psychologic distress.

Cristina Almansa1, Enrique Rey, Raquel García Sánchez, Angel Alvarez Sánchez, Manuel Díaz-Rubio.   

Abstract

BACKGROUND & AIMS: Fibromyalgia is a rheumatologic disorder associated with somatic and psychologic conditions. Although fibromyalgia is associated with irritable bowel syndrome, its relationship with other functional gastrointestinal disorders (FGID) is unclear. We evaluated the prevalence of FGID in patients with fibromyalgia and the role of psychologic factors in this relationship.
METHODS: From a Spanish population, 100 patients with fibromyalgia and 100 matched controls completed the Rome II Integrative Questionnaire to assess the prevalence of FGID and the Symptom Checklist-90 Revised (SCL-90R) to evaluate psychologic distress. Patients completed the Fibromyalgia Impact Questionnaire to evaluate the overall impact of fibromyalgia and controls filled out the Chronic Widespread Pain Questionnaire to detect potential cases of fibromyalgia.
RESULTS: Ninety-three percent of the total study population was female, with a mean age of 50 years. We identified 6 cases of widespread pain among controls. The average Fibromyalgia Impact Questionnaire score for patients was 67.28 +/- 14.25. All gastrointestinal symptoms except for vomiting were more frequent in patients. Ninety-eight percent of patients with fibromyalgia had at least one FGID, compared with only 39% of controls. Fibromyalgia was correlated most highly with irritable bowel syndrome. Patients presented with significantly higher scores of psychologic distress than controls, especially those with fecal incontinence.
CONCLUSIONS: There is a prevalence of FGID in patients with fibromyalgia and a wider distribution of such symptoms along the gastrointestinal tract compared with controls. We propose that an increased degree of psychologic distress in these patients predisposes them to FGID, especially significant for anorectal syndromes.

Entities:  

Mesh:

Year:  2008        PMID: 19138763     DOI: 10.1016/j.cgh.2008.12.005

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  19 in total

1.  Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  Roger B Fillingim; Richard Ohrbach; Joel D Greenspan; Charles Knott; Ronald Dubner; Eric Bair; Cristina Baraian; Gary D Slade; William Maixner
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  The spectrum of functional gastrointestinal disorders in a tertiary referral clinic in Ireland.

Authors:  K Walsh; S R McWilliams; M M Maher; E M Quigley
Journal:  Ir J Med Sci       Date:  2011-09-24       Impact factor: 1.568

Review 3.  Rumination Syndrome: Recognition and Treatment.

Authors:  Herit Vachhani; Bruno De Souza Ribeiro; Ron Schey
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-20

4.  Celiac symptoms in patients with fibromyalgia: a cross-sectional study.

Authors:  Juan Miguel García-Leiva; Jorge Luis Ordóñez Carrasco; Mahmoud Slim; Elena P Calandre
Journal:  Rheumatol Int       Date:  2014-08-15       Impact factor: 2.631

Review 5.  An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms.

Authors:  Mahmoud Slim; Elena Pita Calandre; Fernando Rico-Villademoros
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

6.  Colorectal and anal symptoms in women with urinary incontinence and pelvic organ prolapse.

Authors:  Khanh Ha; Christina Dancz; Rebecca Nelken; Mayra Contreras; Begüm Ozel
Journal:  Int Urogynecol J       Date:  2009-10-08       Impact factor: 2.894

7.  Self-reported physical health, mental health, and comorbid diseases among women with irritable bowel syndrome, fibromyalgia, or both compared with healthy control respondents.

Authors:  Peter Przekop; Mark G Haviland; Yan Zhao; Keiji Oda; Kelly R Morton; Gary E Fraser
Journal:  J Am Osteopath Assoc       Date:  2012-11

8.  Psychological factors associated with development of TMD: the OPPERA prospective cohort study.

Authors:  Roger B Fillingim; Richard Ohrbach; Joel D Greenspan; Charles Knott; Luda Diatchenko; Ronald Dubner; Eric Bair; Cristina Baraian; Nicole Mack; Gary D Slade; William Maixner
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

9.  Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome.

Authors:  Jeremy D Gale; Lesley A Houghton
Journal:  Front Pharmacol       Date:  2011-06-09       Impact factor: 5.810

Review 10.  Chronic subordinate colony housing paradigm: a mouse model to characterize the consequences of insufficient glucocorticoid signaling.

Authors:  Dominik Langgartner; Andrea M Füchsl; Nicole Uschold-Schmidt; David A Slattery; Stefan O Reber
Journal:  Front Psychiatry       Date:  2015-02-23       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.